#829 – The Industry Wire

August 26, 2026 Brian Casey 0 min read
  1. FDA approves breakthrough pill for pancreatic cancer. 
  2. Hormone replacement therapy reduces dementia risk in women.
  3. Costs tied to No Surprises Act’s IDR process exceed $22B.
  4. Pennsylvania sees first measles deaths in 35 years.
  5. Shingles vaccine has cardiovascular benefits. 
  6. Boston Scientific operations hit with cyberattack. 
  7. Guardant ordered to pay $245M in DNA sequencing patent dispute.
  8. Study supports vaping for smoking cessation – with caveats.
  9. California voters say healthcare is a top priority.
  10. High-risk women struggle with breast MRI payments. 
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like

Lung Cancer Screening September 17, 2026

Expanding CT Lung Screening at WCLC 2026 September 17, 2026

Presentations at this week’s WCLC 2026 discussed how to make low-dose CT lung cancer screening available to as many eligible people as possible.

Artificial Intelligence September 14, 2026

Top 10 AI Vendors by FDA Approvals September 14, 2026

Radiology maintained its lead in FDA approvals for AI-enabled medical devices in new data released by the agency.

Artificial Intelligence September 10, 2026

Harrison’s Teleradiology Play September 10, 2026

AI developer Harrison.ai is expanding its business model by supporting a teleradiology venture called Frontier Radiology that’s scaling up and hiring radiologists.